The suitability of therapeutic effort: An end-of-life strategy

Semergen
F M Pérez Pérez

Abstract

End-of-life treatment and attention to the needs of relatives are not adequate for several reasons: Society denies or hides the death; it is very difficult to predict it accurately; treatment is frequently fragmented between different specialists, and there is insufficient palliative medicine training, including communication skills. There are frequent conflicts with decisions made at the end of life, particularly the suitability of therapeutic effort. The attitude of professionals on the adequacy of therapeutic effort is not homogenous, and varies depending on the specialty, experience, and beliefs. Many doctors are still afraid of inconveniencing patients. Primary care is in a privileged position to approach the life and values of our patients and their families, and not just the disease, which makes it the right place to guide and advise the patient on the preparation and registration of living wills.

References

Nov 1, 1996·Chest·T J Prendergast, T A Raffin
Dec 21, 2000·JAMA : the Journal of the American Medical Association·C F von GuntenL L Emanuel
Oct 6, 2001·Critical Care Medicine·F PochardUNKNOWN French PROTOCETIC Group
Dec 26, 2001·JAMA : the Journal of the American Medical Association·D E MeierR S Morrison
May 1, 2002·JAMA : the Journal of the American Medical Association·Harvey Max Chochinov
May 15, 2003·JAMA : the Journal of the American Medical Association·June R LunneyJack M Guralnik
May 24, 2003·Applied Nursing Research : ANR·Karin T KirchhoffPrashanth Reddy Anumandla
Aug 14, 2003·JAMA : the Journal of the American Medical Association·Charles L SprungUNKNOWN Ethicus Study Group
Oct 14, 2004·JAMA : the Journal of the American Medical Association·David E Weissman
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Harvey Max Chochinov
Mar 8, 2006·Critical Care Medicine·M GiacominiE Gedge
Apr 17, 2007·Health Policy·Joke LemiengreChris Gastmans
Feb 19, 2008·Critical Care : the Official Journal of the Critical Care Forum·Anders Rydvall, Niels Lynöe
Apr 24, 2008·Critical Care Medicine·Robert D TruogUNKNOWN American Academy of Critical Care Medicine
Aug 8, 2008·Current Opinion in Supportive and Palliative Care·Jorge H Eisenchlas
Aug 26, 2009·Academic Medicine : Journal of the Association of American Medical Colleges·Tim J WilkinsonL Doug Knock
Sep 2, 2009·Annals of Internal Medicine·Timothy E QuillAnthony L Back
Dec 31, 2009·JAMA : the Journal of the American Medical Association·David B Reuben
Feb 12, 2010·The New England Journal of Medicine·Robert D Truog
Mar 3, 2010·American Journal of Respiratory and Critical Care Medicine·John M Luce
May 28, 2010·The New England Journal of Medicine·Douglas W Hanto, Keren Ladin
Apr 19, 2011·Gaceta sanitaria·Tomás VegaUNKNOWN por el Grupo RECENT
May 4, 2011·Revista clínica española·E AmeneirosA Fernández
Mar 27, 2012·Gaceta sanitaria·Fernando Andrés-PretelJesús López-Torres Hidalgo
Jul 6, 2013·Atencion primaria·Rafael Toro FloresMaría Teresa Alfonso Galán
Oct 8, 2013·Semergen·M M Álvarez-CordovésB Chávez-Díaz

❮ Previous
Next ❯

Citations

Apr 4, 2021·Children·Gregorio Zuniga-VillanuevaRegina Okhuysen-Cawley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved